Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Comments to the USPTO’s MAY 10, 2024 Proposed…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
Learn more
Comments of the Biotechnology Innovation…
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
Learn more
BIO Comments to FWS on Use of GMOs on National…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
Biodefense: 2009 National Strategy for Countering Biological Threats
March 10, 2016
White House National Security Council - November 2009 National Strategy for Countering Biological Threats
Federal Register Notice of 2010 TIP Competition: NIST issues notice of 2010 TIP competition
March 10, 2016
NIST includes biomanufacturing as an area of "critical national need" for 2010 TIP competition.
Promoting Health and Preventing Disease: Childhood and Adult Vaccine Updates and Recommendations
March 10, 2016
Centers for Disease Control & Prevention, Clinician Outreach and Community Activity (COCA) Conference Call July 27, 2010.
Biodefense: 2010 National Security Strategy
March 10, 2016
May 2010 National Security Strategy from the White House
Amendment to Federal Register Notice: NIST issues amendments 2010 TIP competition
March 10, 2016
NIST clarifies that device development is not a focus of 2010 TIP competition.
Vaccines: 2008 Draft Strategic National Vaccine Plan
March 10, 2016
The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.
Agriculture and Weed Resistance
March 10, 2016
The environmental challenges of weed resistance are the same for biotech crops and conventional crops if farmers do not use herbicides as directed. Learn more about stewardship practices that help farmers better control weeds and how biotechnology…
Cures Acceleration Network: Patient Group Letter
March 10, 2016
The letter, signed by approximately 85 patient groups, requests appropriation for CAN in FY2011
Technological Innovation Program (TIP): NIST proposes new program support, promote, and accelerate innovation in the United States through high-risk, high-reward research in areas of critical national need.
March 10, 2016
BIO applauds NIST on implementation of TIP program and urges that personalized medicine be included as an area of "critical national need"
Sarbanes-Oxley in Financial Services Compromise: Sarbanes-Oxley 404(b) Legislative Text in the Wall Street Reform and Consumer Protection Act of 2009
March 10, 2016
BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.